z.laurent

TL2 Moderator · Tampere

Contributes reviews on supplier material. Based in Tampere.

Joined 15 January 2025 · last posted 6h

76 posts, newest first. Showing up to 150.

What I would want from a home test that does not exist yet Replied, post #51 · Analytics › Home & field testing · 28 Jul 2026 · 9 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
Insurance and replacement policies, compared Replied, post #114 · Sourcing › Logistics · 24 Jul 2026 · 27 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #57 · Pharmacology › Pharmacokinetics · 21 Jul 2026 · 4 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
What a statistical analysis plan adds that the paper does not Replied, post #2 · marked as the solution · Evidence › Trials · 21 Jul 2026 · 26 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
What a reversed-phase purity number actually is Replied, post #52 · Analytics › HPLC & UHPLC · 14 Jul 2026 · 2 likes Coming back to post #50, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
An appeal that succeeded, with the letter structure Replied, post #14 · Access › Insurance & coverage · 12 Jul 2026 · 9 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
A single out-of-range value on an otherwise normal panel Replied, post #71 · Clinical › Bloodwork · 11 Jul 2026 · 1 like Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
Publication bias detection and its low power Replied, post #2 · Evidence › Meta-analyses · 10 Jul 2026 · 8 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
Pooling trials with different estimands Replied, post #74 · Evidence › Meta-analyses · 6 Jul 2026 · 28 likes post #73 answers the question as asked. The question underneath it is different. Number needed to treat from a meta-analysis: can be computed from the pooled estimate…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #109 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 11 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #61 · Sourcing › Independent verification · 3 Jul 2026 · 6 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
An 18-month record including the parts that went badly Replied, post #36 · Outcomes › Progress reports · 9 Jun 2026 · 21 likes Medication changes: escalating dose, or adding or removing other medications, can affect the rate of weight loss. Documenting medication changes alongside weight makes…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #46 · Practice › Dosing & titration · 6 Jun 2026 · 2 likes Worth separating two things that post #42 runs together. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials…
Why the titration planner refuses to produce a schedule below a floor Replied, post #79 · Data & Tools › Calculators · 28 May 2026 · 16 likes Coming back to post #77, because the follow-up matters more than the original answer. Why calculators are not medical advice: they do arithmetic. Medical decisions are…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #35 · Practice › Dosing & titration · 20 May 2026 · 8 likes This follows post #32 rather than contradicting it. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure,…
Batch numbers that do not match the vial label Replied, post #17 · Sourcing › Red flags · 17 May 2026 · 0 likes post #16 answers the question as asked. The question underneath it is different. Exaggerated claims without documentation: every compound has limits. No peptide is…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #39 · Devices › Syringes & needles · 12 May 2026 · 2 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
A plateau that disappeared when I changed how I measured — the long version Replied, post #33 · Outcomes › Progress reports · 2 May 2026 · 0 likes Picking up post #30: that is the part I would want checked first. Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is…
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #5 · Practice › Side effects · 24 Apr 2026 · 0 likes Worth separating two things that the opening post runs together. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain,…
Tracking intake honestly when appetite is absent Replied, post #2 · Nutrition & Training › Protein & intake · 16 Apr 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Type 2 diabetes and the largest part of the evidence base Replied, post #64 · Clinical › Comorbidities · 11 Apr 2026 · 15 likes Worth separating two things that post #60 runs together. Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit…
Spike-and-recover accuracy for a peptide assay Replied, post #72 · Analytics › Method validation · 9 Apr 2026 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #98 · Pharmacology › Pharmacokinetics · 8 Apr 2026 · 28 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
Follow-up: State-level differences that actually matter Replied, post #30 · Regional › North America · 5 Apr 2026 · 8 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
Run-in periods and the population they select Replied, post #93 · Evidence › Trials · 3 Apr 2026 · 0 likes I read post #91 twice before replying, because I had assumed the opposite. The estimand: what the trial set out to estimate. Two trials can be identical in structure…
Labelling requirements for research chemicals Replied, post #8 · Sourcing › Regulatory · 3 Apr 2026 · 4 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
[2026 update] Composite endpoints and the component doing the work Replied, post #34 · Evidence › Trials · 17 Mar 2026 · 25 likes post #33 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #13 · Evidence › Journal club · 9 Mar 2026 · 16 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
The lowest dose that does anything: is that a real question? Replied, post #21 · Practice › Dosing & titration · 2 Mar 2026 · 0 likes post #20 is right about the mechanism and I think understates the practical bit. Holding a dose indefinitely: the trials did not study indefinite holding at a…
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #13 · Compounds › Repair & healing peptides · 27 Feb 2026 · 1 like Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
[2026 update] Thyroid function tests during substantial weight change Replied, post #5 · Clinical › Bloodwork · 27 Feb 2026 · 16 likes On the opening post — agreed on the reasoning, with one qualification. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin…
Follow-up: Search filters: what is missing Replied, post #40 · Meta › Site feedback · 24 Feb 2026 · 0 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
Measurement error in a self-reported exposure Replied, post #42 · Evidence › Study critique · 24 Feb 2026 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
[2026 update] Availability by country, dated, with primary sources Replied, post #19 · Access › International · 30 Jan 2026 · 25 likes Worth separating two things that post #15 runs together. Insurance and coverage: coverage decisions are national. A compound approved in one country might not be…
Coming back to: Training through a dose escalation week Replied, post #16 · Nutrition & Training › Resistance training · 27 Jan 2026 · 0 likes post #15 answers the question as asked. The question underneath it is different. Frequency: three sessions per week of full-body training is easier to maintain than…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #24 · Evidence › Trials · 14 Dec 2025 · 7 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #6 · Compounds › Oral incretins · 25 Nov 2025 · 0 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
Bleeding at the injection site: normal, and what to do about it Replied, post #4 · Practice › Administration · 22 Nov 2025 · 0 likes post #2 answers the question as asked. The question underneath it is different. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #26 · Practice › Side effects · 15 Nov 2025 · 0 likes This follows post #23 rather than contradicting it. Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in…
Why the titration planner refuses to produce a schedule below a floor Replied, post #10 · Data & Tools › Calculators · 15 Nov 2025 · 26 likes I read post #8 twice before replying, because I had assumed the opposite. The calculators maintained on this site are open-source and verifiable. They are intended to…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #9 · Clinical › Bloodwork · 11 Nov 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #22 · Compounds › Oral incretins · 29 Oct 2025 · 3 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
Availability by country, dated, with primary sources Replied, post #30 · Access › International · 22 Oct 2025 · 10 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
Request: a diff view for wiki revisions — the long version Replied, post #48 · Meta › Feature requests · 27 Sep 2025 · 2 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #100 · Evidence › Study critique · 15 Sep 2025 · 0 likes On post #96 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
Hepatic impairment and the absence of data Replied, post #25 · Clinical › Special populations · 2 Sep 2025 · 29 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
When a preprint is the best available evidence and we say so Replied, post #127 · Evidence › Preprints · 1 Sep 2025 · 0 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #116 · Compounds › Secretagogues & GH axis · 30 Aug 2025 · 0 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
Substitution between formats during a shortage Replied, post #38 · Access › Shortages · 13 Aug 2025 · 3 likes post #37 answers the question as asked. The question underneath it is different. Patient advocacy during shortages: some advocacy groups advocate for patients during…
Antibiotics and a course of something with delayed emptying Replied, post #105 · Practice › Interactions · 31 Jul 2025 · 21 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
Criticising the method without criticising the authors — one year on Replied, post #14 · Evidence › Study critique · 29 Jul 2025 · 3 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
Managing an unplanned gap in supply — what changed since Replied, post #21 · Access › Shortages · 21 Jul 2025 · 0 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
Lyophilisation and why the cake looks the way it does Replied, post #8 · Pharmacology › Formulation chemistry · 13 Jul 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #20 · Evidence › Journal club · 10 Jul 2025 · 9 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Specification in the result column: why that is a meaningful error Replied, post #14 · Analytics › COA interpretation · 1 Jul 2025 · 0 likes post #13 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Micronutrient status when intake falls substantially Replied, post #11 · Clinical › Bloodwork · 16 Jun 2025 · 1 like Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
Coming back to: An 18-month record including the parts that went badly Replied, post #50 · Outcomes › Progress reports · 10 May 2025 · 0 likes On post #46 — agreed on the reasoning, with one qualification. Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #34 · Sourcing › Independent verification · 7 May 2025 · 18 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
When "no data" is the complete and final answer Replied, post #160 · Compounds › Other compounds · 26 Apr 2025 · 0 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
Deamidation and the close-eluting pair it produces Replied, post #29 · Analytics › Impurities & related substances · 20 Apr 2025 · 5 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #129 · Compounds › Semaglutide · 2 Apr 2025 · 20 likes On post #125 — agreed on the reasoning, with one qualification. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #5 · Evidence › Journal club · 27 Mar 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
A ten-fold dose error caught before injection Replied, post #13 · Devices › Syringes & needles · 26 Mar 2025 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
Pancreatitis history and the risk calculus — a second dataset Replied, post #26 · Safety › Contraindications · 7 Mar 2025 · 0 likes post #25 answers the question as asked. The question underneath it is different. Severe renal impairment (eGFR
A promotion I argued against, and why I lost Replied, post #122 · Documentation › Doc review · 6 Mar 2025 · 0 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
What we do not know about retatrutide, listed explicitly Replied, post #110 · Compounds › Retatrutide · 24 Feb 2025 · 4 likes Coming back to post #108, because the follow-up matters more than the original answer. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude…
Journal club: SURMOUNT-1, read without the press release Replied, post #60 · Evidence › Journal club · 13 Feb 2025 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
Fixed versus detachable needles: the trade-offs Replied, post #73 · Devices › Syringes & needles · 26 Dec 2024 · 0 likes Coming back to post #71, because the follow-up matters more than the original answer. Dead volume: residual liquid in the hub and needle after withdrawal. Typical…
When "no data" is the complete and final answer Replied, post #42 · Compounds › Other compounds · 15 Dec 2024 · 0 likes I read post #40 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
Units, standards, and other things that quietly hold the world together — one year on Replied, post #2 · Lounge › Off topic · 3 Nov 2024 · 0 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #52 · Wellbeing › Mental health · 26 Oct 2024 · 18 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #46 · Clinical › Comorbidities · 16 Oct 2024 · 11 likes On post #42 — agreed on the reasoning, with one qualification. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #64 · Nutrition & Training › Hydration & electrolytes · 29 Aug 2024 · 2 likes This follows post #61 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
Journal club: FLOW and the renal composite, component by component Replied, post #3 · Evidence › Journal club · 7 Jul 2024 · 9 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
The mass-error checker and its intended scope Replied, post #86 · Data & Tools › Calculators · 30 Jun 2024 · 25 likes This follows post #83 rather than contradicting it. The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not…
Assessing a warm arrival: the decision process — one year on Replied, post #3 · Sourcing › Logistics · 28 May 2024 · 1 like Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…